… Series – Usher Syndrome and Retinitis Pigmentosa ProQR Expert Perspectives Series on Usher Syndrome and … Pigmentosa with Aniz Girach, MD, Chief Medical Officer of ProQR Therapeutics, and Robert Koenekoop, MD, PhD of McGill … link . lun 22/06/2020 - 12:00 - lun 22/06/2020 - 13:00 ProQR Expert Perspectives Series on Usher Syndrome and …
… and Peptide Therapeutics Conference (TIDES USA) ProQR presentation Presentation title: Unlocking the … Platenburg, Co-Founder and Chief Scientific Officer at ProQR Presentation type: Oral presentation Session: … PDT mar 09/05/2023 - 00:00 - mar 09/05/2023 - 23:59 ProQR will be at the TIDES USA meeting, May 7-10, 2023 in San …
… Axiomer Investor Call ProQR management will host an investor conference call and … date. Download the presentation About Axiomer ® ProQR is pioneering a next-generation RNA editing technology … jeu 09/09/2021 - 14:15 - jeu 09/09/2021 - 15:15 ProQR management will host an investor conference call and …
ProQR will review the recently reported AX-0810 Phase 1 target engagement data and discuss the translational rationale and clinical development strategy for NTCP modulation in biliary atresia, including the framework for evaluating upcoming next-generation AX-0811 Phase 1 data and its potential to treat cholestatic disease.